RhAPPcast podcast

Medication Review: What Real-World Evidence Supports the Effectiveness of Belimumab in SLE?

11/10/2026
0:00
1:18
Rewind 15 seconds
Fast Forward 15 seconds

In this Medication Review video, Jennifer Mylod, DNP, discusses recent real-world evidence supporting the effectiveness and safety of belimumab in systemic lupus erythematosus (SLE). As one of the most established biologic therapies for lupus, belimumab continues to demonstrate meaningful benefits for patients across a range of clinical settings.

This educational discussion reviews real-world data showing improvements in disease activity, flare reduction, serologic markers, and corticosteroid use among patients treated with belimumab. Jennifer also highlights findings from lupus nephritis studies, which have demonstrated improvements in proteinuria and renal response rates when belimumab is added to standard therapy.

Watch now to learn more about the long-term safety and effectiveness of belimumab, including commonly reported adverse events and the reassuring safety profile observed since its approval more than 15 years ago. For more expert-led education, visit the Content Rheum and download the RhAPP Ace app to stay up to date with the latest clinical insights in rheumatologic care.

More episodes from "RhAPPcast"